Characterization of the phosphoproteome in LNCaP prostate cancer cells by in-gel isoelectric focusing and tandem mass spectrometry

Journal of Proteome Research

Volumn 9, Issue 1, 2010, Pages 174-178

  Chen, Li ^a   Giorgianni, Francesco ^a   Beranova Giorgianni, Sarka ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

IEF; IMAC; LC MS MS; LNCaP; Phosphoprotein; Prostate cancer

Indexed keywords

PHOSPHOPEPTIDE; PROTEOME; TRYPSIN;

AMINO ACID SEQUENCE; ARTICLE; CELL STRAIN LNCAP; HUMAN; HUMAN CELL; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; ISOELECTRIC FOCUSING; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SEQUENCE DATABASE; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; HUMANS; HYDROGEN-ION CONCENTRATION; ISOELECTRIC FOCUSING; MALE; PHOSPHOPROTEINS; PROSTATIC NEOPLASMS; PROTEOME; SUBCELLULAR FRACTIONS; TANDEM MASS SPECTROMETRY;

EID: 73649143900     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900338q     Document Type: Article

References (26)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58, 71-96.
2. Cohen, P. The regulation of protein function by multisite phosphorylationsa 25 year update. Trends Biochem. Sci. 2000, 25, 596-601.
3. Lim, Y. P. Mining the tumor phosphoproteome for cancer markers. Clin. Cancer Res. 2005, 11, 3163-3169.
4. Stephens, B. J.; Han, H.; Gokhale, V.; Von Hoff, D. D. PRL phosphatases as potential molecular targets in cancer. Mol. Cancer Ther. 2005, 4, 1653-1661.
5. Iakoucheva, L. M.; Radivojac, P.; Brown, C. J.; O'Connor, T. R.; Sikes, J. G.; Obradovic, Z.; Dunker, A. K. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 2004, 32, 1037-1049.
6. Benzeno, S.; Lu, F.; Guo, M.; Barbash, O.; Zhang, F.; Herman, J. G.; Klein, P. S.; Rustgi, A.; Diehl, J. A. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 2006, 25, 6291-6303.
7. Collins, M. O.; Yu, L.; Choudhary, J. S. Analysis of protein phosphorylation on a proteome-scale. Proteomics. 2007, 7, 2751-2768.
8. Gafken, P. R.; Lampe, P. D. Methodologies for characterizing phosphoproteins by mass spectrometry. Cell Commun. Adhes. 2006, 13, 249-262.
9. Hoffert, J. D.; Knepper, M. A. Taking aim at shotgun phosphoproteomics. Anal. Biochem. 2008, 375, 1-10.
10. Giorgianni, F.; Zhao, Y.; Desiderio, D. M.; Beranova-Giorgianni, S. Toward a global characterization of the phosphoproteome in prostate cancer cells: Identification of phosphoproteins in the LNCaP cell line. Electrophoresis 2007, 28, 2027-2034.
11. Giorgianni, F.; Desiderio, D. M.; Beranova-Giorgianni, S. Proteome analysis using isoelectric focusing in immobilized pH gradient gels followed by mass spectrometry. Electrophoresis 2003, 24, 253-259.
12. Zhao, Y.; Giorgianni, F.; Desiderio, D. M.; Fang, B.; Beranova-Giorgianni, S. Toward a global analysis of the human pituitary proteome by multiple gel-based technology. Anal. Chem. 2005, 77, 5324-5331.
13. Beranova-Giorgianni, S.; Zhao, Y.; Desiderio, D. M.; Giorgianni, F. Phosphoproteomic analysis of the human pituitary. Pituitary 2006, 9, 109-120.
14. Ballif, B. A.; Carey, G. R.; Sunyaev, S. R.; Gygi, S. P. Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain. J. Proteome Res. 2008, 7, 311-318.
15. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 2007, 4, 207-214.
16. DeGnore, J. P.; Qin, J. Fragmentation of phosphopeptides in an ion trap mass spectrometer. J. Am. Soc. Mass Spectrom. 1998, 9, 1175-1188.
17. Lee, J. T.; Lehmann, B. D.; Terrian, D. M.; Chappell, W. H.; Stivala, F.; Libra, M.; Martelli, A. M.; Steelman, L. S.; McCubrey, J. A. Targeting prostate cancer based on signal transduction and cell cycle pathways. Cell Cycle 2008, 7, 1745-1762.
18. Kreisberg, J. I.; Malik, S. N.; Prihoda, T. J.; Bedolla, R. G.; Troyer, D. A.; Kreisberg, S.; Ghosh, P. M. Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res. 2004, 64, 5232-5236.
19. Chen, H. M.; Schmeichel, K. L.; Mian, I. S.; Lelievre, S.; Petersen, O. W.; Bissell, M. J. AZU-1: a candidate breast tumor suppressor and biomarker for tumor progression. Mol. Biol. Cell 2000, 11, 1357-1367.
20. Yang, H. S.; Matthews, C. P.; Clair, T.; Wang, Q.; Baker, A. R.; Li, C. C.; Tan, T. H.; Colburn, N. H. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol. Cell. Biol. 2006, 26, 1297-1306.
21. Edwards, J.; Bartlett, J. M. The androgen receptor and signaltransduction pathways in hormone-refractory prostate cancerPart 1: Modifications to the androgen receptor. BJU Int. 2005, 95, 1320-1326.
22. Lee, H. J.; Chang, C. Recent advances in androgen receptor action. Cell. Mol. Life Sci. 2003, 60, 1613-1622.
23. Rochette-Egly, C. Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell. Signalling 2003, 15, 355-366.
24. Lahn, M.; Sundell, K.; Gleave, M.; Ladan, F.; Su, C.; Li, S.; Ma, D.; Paterson, B. M.; Bumol, T. F. Protein kinase C-alpha in prostate cancer. BJU Int. 2004, 93, 1076-1081.
25. Gioeli, D. Signal transduction in prostate cancer progression. Clin. Sci. 2005, 108, 293-308.
26. Mann, M. Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 2006, 7, 952-958.